In particular, in a study of paclitaxel-treated patients with ovarian cancer, carriers of ABCB1 3435T or 1236T experienced a severe neutropenia as compared with carriers of the C allele (p=0.03 and p=0.06 respectively) [177]. Here, ABCB1 is linked to neutropenia.